Worldwide reports of counterfeit drugs have increased more than ten-fold from 2002 to 2010. The surge also leads to an increase in the risk of counterfeit drugs infiltrating Europe’s legal distribution system.
“Counterfeiting is an increasing problem world-wide. In the chain of legal distribution there is a higher risk of counterfeiting. We have seen it in Europe, and the US is highly affected by it as well, and China probably to an even larger extent,” says Ulla Høegh, chief consultant for LIF – the Danish pharmaceutical industry union.